Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis

Annals of Surgical Oncology

Volumn 19, Issue 2, 2012, Pages 402-408

  Pilati, Pierluigi ^a   Mocellin, Simone ^a   Bertazza, Loris ^a,b   Galdi, Francesca ^a   Briarava, Marta ^a   Mammano, Enzo ^a   Tessari, Emanuela ^a   Zavagno, Giorgio ^a   Nitti, Donato ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 20; EPIDERMAL GROWTH FACTOR RECEPTOR; SURVIVIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STEM CELL; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; MALE; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; UNIVARIATE ANALYSIS;

AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84856680480     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2132-2     Document Type: Article

References (42)

1. JN Primrose 2010 Surgery for colorectal liver metastases Br J Cancer. 102 1313 1318 20424612 10.1038/sj.bjc.6605659 1:STN:280:DC%2BC3c3psVSrsw%3D%3D
2. M Lise S Mocellin P Pilati D Nitti 2005 Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches Front Biosci. 10 3042 3057 15970559 10.2741/1761 1:CAS:528: DC%2BD2MXntFGit7s%3D
3. N Kemeny 2010 The management of resectable and unresectable liver metastases from colorectal cancer Curr Opin Oncol. 22 364 373 20520544 10.1097/CCO.0b013e32833a6c8a
4. SC Mayo TM Pawlik 2009 Current management of colorectal hepatic metastasis Expert Rev Gastroenterol Hepatol. 3 131 144 19351284 10.1586/egh.09.8
5. DG Power NE Kemeny 2010 Role of adjuvant therapy after resection of colorectal cancer liver metastases J Clin Oncol. 28 2300 2309 20368552 10.1200/JCO.2009.26.9340 1:CAS:528:DC%2BC3cXpsFSgtL4%3D
6. Nelson R, Freels S. Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Cochrane Database Syst Rev. 2006;(4):CD003770.
7. L Ruo RP DeMatteo LH Blumgart 2001 The role of adjuvant therapy after liver resection for colorectal cancer metastases Clin Colorectal Cancer. 1 154 166 12450428 10.3816/CCC.2001.n.016 1:CAS:528:DC%2BD38Xntl2ntL4%3D
8. RK Kelley SL Van Bebber KA Phillips AP Venook 2010 Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer J Natl Compr Canc Netw. 9 13 25
9. S Mocellin M Lise D Nitti 2005 Targeted therapy for colorectal cancer: mapping the way Trends Mol Med. 11 327 335 15950539 10.1016/j.molmed.2005.05.002 1:CAS:528:DC%2BD2MXlvFKlt7c%3D
10. NN Rahbari M Aigner K Thorlund, et al. 2010 Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer Gastroenterology. 138 1714 1726 20100481 10.1053/j.gastro. 2010.01.008
11. G Peach C Kim E Zacharakis, et al. 2010 Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review Br J Cancer. 102 1327 1334 20389297 10.1038/sj.bjc.6605651 1:STN:280:DC%2BC3c3pt1Oktg%3D%3D
12. JE Allen WS El-Deiry 2010 Circulating tumor cells and colorectal cancer Curr Colorectal Cancer Rep. 6 212 220 20890370 10.1007/s11888-010-0069-7
13. K Pantel C Alix-Panabieres 2010 Circulating tumour cells in cancer patients: challenges and perspectives Trends Mol Med. 16 398 406 20667783 10.1016/j.molmed.2010.07.001
14. E Dotan SJ Cohen KR Alpaugh NJ Meropol 2009 Circulating tumor cells: evolving evidence and future challenges Oncologist. 14 1070 1082 19897536 10.1634/theoncologist.2009-0094
15. S Mocellin U Keilholz CR Rossi D Nitti 2006 Circulating tumor cells: the "leukemic phase" of solid cancers Trends Mol Med. 12 130 139 16488189 10.1016/j.molmed.2006.01.006 1:CAS:528:DC%2BD28XisF2gtr0%3D
16. S Mocellin D Hoon A Ambrosi, et al. 2006 The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis Clin Cancer Res. 12 4605 4613 16899608 10.1158/1078-0432.CCR-06- 0823 1:CAS:528:DC%2BD28XnvVGks7w%3D
17. Y Fong J Fortner RL Sun, et al. 1999 Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg. 230 309 318 10493478 10.1097/00000658- 199909000-00004 1:STN:280:DyaK1MvitFahsw%3D%3D
18. L Bertazza S Mocellin A Marchet, et al. 2009 Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival J Transl Med 7 111 20028510 10.1186/1479-5876-7-111
19. S Mocellin P Del Fiore L Guarnieri, et al. 2004 Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma Int J Cancer. 111 741 745 15252844 10.1002/ijc.20347 1:CAS:528:DC%2BD2cXmvVenurY%3D
20. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method Methods. 25 402 408 11846609 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D
21. Grambsch TM, Therneau M. Modelling survival data. New York: Springer, 2000.
22. M Schemper TL Smith 1996 A note on quantifying follow-up in studies of failure time Control Clin Trials. 17 343 346 8889347 10.1016/0197-2456(96)00075- X 1:STN:280:DyaK2s%2FksVaktA%3D%3D
23. TG Clark DG Altman BL De Stavola 2002 Quantification of the completeness of follow-up Lancet 359 9314 1309 1310 11965278 10.1016/S0140-6736(02)08272-7
24. O Harel XH Zhou 2007 Multiple imputation: review of theory, implementation and software Stat Med. 26 3057 3077 17256804 10.1002/sim.2787
25. M Hebbar FR Pruvot O Romano, et al. 2009 Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer Cancer Treat Rev. 35 668 675 19733977 10.1016/j.ctrv.2009.08. 005 1:CAS:528:DC%2BD1MXhsVGlsb3K
26. National Comprehensive Cancer Network. Colon cancer. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. http://www.nccn.org/.
27. A Walther E Johnstone C Swanton, et al. 2009 Genetic prognostic and predictive markers in colorectal cancer Nat Rev Cancer. 9 489 499 19536109 10.1038/nrc2645 1:CAS:528:DC%2BD1MXnsVagtbY%3D
28. L Weiss 1990 Metastatic inefficiency Adv Cancer Res. 54 159 211 1688681 10.1016/S0065-230X(08)60811-8 1:STN:280:DyaK3c7hvFSisw%3D%3D
29. M Yu S Stott M Toner, et al. 2010 Circulating tumor cells: approaches to isolation and characterization J Cell Biol. 192 373 382 10.1083/jcb.201010021
30. Punnoose EA, Atwal SK, Spoerke JM, et al. Molecular biomarker analyses using circulating tumor cells. PLoS One. 2011;5:12517.
31. S Riethdorf K Pantel 2010 Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells Ann N Y Acad Sci. 1210 66 77 20973800 10.1111/j.1749-6632.2010.05779.x 1:CAS:528: DC%2BC3cXhsFOntLnI
32. L Ricci-Vitiani DG Lombardi E Pilozzi, et al. 2007 Identification and expansion of human colon-cancer-initiating cells Nature 445 7123 111 115 17122771 10.1038/nature05384 1:CAS:528:DC%2BD2sXhsFOmug%3D%3D
33. CA O'Brien A Pollett S Gallinger JE Dick 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 7123 106 110 17122772 10.1038/nature05372
34. SS Zeki TA Graham NA Wright 2011 Stem cells and their implications for colorectal cancer Nat Rev Gastroenterol Hepatol. 8 90 100 21293509 10.1038/nrgastro.2010.211
35. M Todaro MG Francipane JP Medema G Stassi 2011 Colon cancer stem cells: promise of targeted therapy Gastroenterology. 138 2151 2162 10.1053/j.gastro. 2009.12.063
36. - metastatic colon cancer cells initiate tumors J Clin Invest. 118 2111 2120 18497886 1:CAS:528:DC%2BD1cXntVCmtLk%3D
37. K Nakamura H Iinuma Y Aoyagi, et al. 2011 Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery Oncology. 78 309 315 10.1159/000318862
38. R Artells I Moreno T Diaz, et al. 2011 Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients Eur J Cancer. 46 642 649 10.1016/j.ejca.2009.11.003
39. D Horst L Kriegl J Engel, et al. 2008 CD133 expression is an independent prognostic marker for low survival in colorectal cancer Br J Cancer. 99 1285 1289 18781171 10.1038/sj.bjc.6604664 1:CAS:528:DC%2BD1cXht1Cmtr%2FP
40. A Lugli G Iezzi I Hostettler, et al. 2011 Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44 s, EpCAM, and ALDH1 in colorectal cancer Br J Cancer. 103 382 390 10.1038/sj.bjc.6605762
41. P Gazzaniga A Gradilone A Petracca, et al. 2011 Molecular markers in circulating tumour cells from metastatic colorectal cancer patients J Cell Mol Med. 14 2073 2077 10.1111/j.1582-4934.2010.01117.x
42. EH Lin M Hassan Y Li, et al. 2007 Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence Cancer. 110 534 542 17594720 10.1002/cncr.22774 1:CAS:528:DC%2BD2sXpt1yqu7w%3D